PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026Recent Advances in Anti-Infective Drug Discovery0 citations

Synthesis, In silico Studies, and Biological Evaluation of Benzotriazole-Fused Thiazole-containing Schiff Bases as Potential Therapeutic Agents for Microbial Infections in Respiratory Disorders

View Full Paper
SKSushil KumarNGNeelima GuptaJSJatin Kishore Sharma

Key Points

  • This research aims to develop and evaluate thiazole-containing Schiff bases as potential antimicrobial agents for respiratory infections.
  • Synthesis and characterization of Schiff base compounds (9a-9h) using spectroscopy and chromatography techniques.
  • Computational analysis including molecular docking and ADME profiling compared to standard drugs.
  • Antimicrobial efficacy was assessed using broth microdilution method against Escherichia coli, Bacillus subtilis, and Candida albicans.
  • Compound 9c showed potent antimicrobial activity with MIC values of 12.76 μg/mL against B. subtilis and 25.52 μg/mL against C. albicans.
  • Compound 9g demonstrated strong activity against E. coli with an MIC value of 12.76 μg/mL.
  • Computational analyses validated the structural stability and bioactive potential of the synthesized compounds.

Abstract

INTRODUCTION: Respiratory disorders pose a significant global health challenge, often worsened by bacterial and fungal infections. Schiff bases have gained attention for their antimicrobial properties, making them promising candidates for drug development and potential patent applications. This study explores the synthesis, computational analysis, and biological evaluation of thiazole-containing Schiff bases as therapeutic agents. MATERIALS AND METHODS: A series of Schiff base compounds (9a-9h) was synthesized and characterized using spectroscopy and chromatography techniques. Computational studies, including molecular docking, ADME profiling, and physicochemical analyses, were performed to compare them with standard antimicrobial drugs (Amoxicillin and Fluconazole). Antimicrobial efficacy was assessed against Escherichia coli, Bacillus subtilis, and Candida albicans using the broth microdilution method in 96-well plates to determine minimum inhibitory concentrations (MICs). RESULTS: Among the synthesized compounds, 9c exhibited potent antimicrobial activity, with MIC values of 12.76 μg/mL against B. subtilis and 25.52 μg/mL against C. albicans. Compound 9g showed strong activity against E. coli, with an MIC value of 12.76 μg/mL. Spectroscopic and computational analyses validated their structural stability and bioactive potential. DISCUSSION: The observed antimicrobial activity highlights the therapeutic promise of thiazole-containing Schiff bases in combating microbial infections associated with respiratory diseases. Their potency, compared to standard antibiotics and antifungal agents, underscores the need for further pharmacological evaluation, optimization, and patent consideration. CONCLUSION: Thiazole-containing Schiff bases demonstrate significant antimicrobial potential, particularly against respiratory-related pathogens. These findings warrant further investigation into their pharmacological properties to develop new treatment options for microbial infections in respiratory disorders, with scope for patentable innovations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kumar et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc64adee9eb8c0dce77aahttps://doi.org/10.2174/0127724344445896260519142339
Ask AI
Helpful
Bookmark
Share
View Full Paper